Male breast cancer accounts for around 1% of all breast cancer cases, but the incidence has
increased over the past 25years. The rarity of this entity precludes prospective randomized …

Breast cancer is a rare disease in men representing nearly 1% of the total breast cancer
cases worldwide. Due to the low incidence, there are no randomized clinical studies giving …

Aims Male breast cancer incidence is 1% of all breast cancers and is increasing. We aim to
present an overview of male breast cancer with particular emphasis on clinical …

Male breast cancer (MBC) is a rare condition that accounts for 0.1% of all male cancers. Our
current evidence base for treatment is derived from female breast cancer (FBC) patients …

Male breast cancer is rare. Median age at diagnosis is~ 65 years, and> 35% of male breast
cancers occur in elderly men. Retroareolar lump is the most frequent symptom, and 25–30 …

Male breast cancer is a rare disease, accounting for less than 1% of all breast cancer
diagnoses worldwide. Most data on male breast cancer comes from small single-institution …

Male breast cancer is rare, accounting for 1% of all breast cancer diagnoses in the USA.
Because of its rarity, most major breast cancer trials have included only female patients. This …

Male breast cancer (MaBC) is a rare clinical entity, which makes up approximately 1% of all
breast cancers. However, the incidence of MaBC has been steadily increasing over the past …

Male breast cancer is a rare malignancy that accounts for less than 1% of all cancers in men
and less than 1% of all breast cancers. But the incidence is rising and in some patient …

Breast cancer is a rare disease in men representing nearly 1% of the total breast cancer
cases worldwide. While treatments developed for women with breast cancer are often …